{
    "key": "2013-0193",
    "name": "Dose 1 to Dose 2 interval 6 mo-4 days.  Series complete.",
    "cdcTestId": "2013-0193",
    "changedInVersion": "3.5",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-05-29T08:29:29.171",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "85",
                "dateAdministered": "2020-02-17T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "Hep A, unspecified formulation"
            },
            {
                "cvx": "85",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "Hep A, unspecified formulation"
            }
        ],
        "seriesStatus": "Complete"
    },
    "evaluationTestType": "Interval: At Absolute Minimum",
    "forecast": {
        "earliestDate": "0001-01-01T00:00:00",
        "forecastNum": "-",
        "pastDueDate": "0001-01-01T00:00:00",
        "recommendedDate": "0001-01-01T00:00:00"
    },
    "forecastTestType": "Not recommended: series complete",
    "generalDescription": "This test case describes when the second dose of the HepA 2 dose vaccine is administered at 6 months - 4 days, that the dose is considered valid and the series is considered complete.",
    "patient": {
        "dob": "2016-02-17T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "85",
                "dateAdministered": "2020-02-17T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "Hep A, unspecified formulation"
            },
            {
                "cvx": "85",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "Hep A, unspecified formulation"
            }
        ]
    },
    "reasonForChange": "V3.5: Lowered Age from 8 years to 4 years to better associate with new Age Groupings. No Effective change to test case other than Age of patient and vaccinations.",
    "testcaseName": "Dose 1 to Dose 2 interval 6 mo-4 days.  Series complete.",
    "vaccineGroup": "HepA"
}